Related Experiment Video
Updated: Aug 14, 2026

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
Published on: March 7, 2019
Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review)
1Department of Plant and Microbial Biology, University of California, Berkeley, CA 94720, USA.
Abstract:
An estimated one-third of genetic disorders are the result of mutations that generate premature termination codons (PTCs) within protein coding genes. These disorders are phenotypically diverse and consist of diseases that affect both young and old individuals. Various small molecules have been identified that are capable of modulating the efficiency of translation termination, including select antibiotics of the aminoglycoside family and multiple novel synthetic molecules, including PTC124. Several of these agents have proved their effectiveness at promoting nonsense suppression in preclinical animal models, as well as in clinical trials. In addition, it has recently been shown that box H/ACA RNA-guided peudouridylation, when directed to modify PTCs, can also promote nonsense suppression. In this review, we summarize our current understanding of eukaryotic translation termination and discuss various methods for promoting the read-through of disease-causing PTCs, as well as the current obstacles that stand in the way of using the discussed agents broadly in clinical practice.
Insights
Genetic disorders caused by premature termination codons (PTCs) can be treated by promoting nonsense suppression. Small molecules and RNA-guided modifications show promise in read-through therapies for these genetic diseases.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Mutations creating premature termination codons (PTCs) account for a significant portion of genetic disorders.
- These disorders exhibit diverse phenotypes, affecting individuals across all age groups.
- Current therapeutic strategies aim to restore protein function by overcoming PTCs.
Purpose of the Study:
- To review current knowledge of eukaryotic translation termination.
- To discuss methods for promoting read-through of disease-causing PTCs.
- To identify obstacles hindering the clinical application of nonsense suppression therapies.
Main Methods:
- Review of existing literature on translation termination and nonsense suppression.
- Analysis of small molecules (e.g., PTC124, aminoglycosides) that modulate translation termination.
- Examination of RNA-guided pseudouridylation as a novel nonsense suppression strategy.
Main Results:
- Several small molecules and RNA-guided modifications have demonstrated efficacy in preclinical and clinical studies for nonsense suppression.
- These agents promote the read-through of PTCs, potentially restoring protein function.
- Box H/ACA RNA-guided pseudouridylation offers a novel approach to nonsense suppression.
Conclusions:
- Therapeutic strategies targeting PTCs hold significant potential for treating a third of genetic disorders.
- Further research is needed to overcome obstacles for broad clinical implementation of these read-through agents.
- Nonsense suppression represents a promising therapeutic avenue for genetic diseases caused by PTCs.
Related Concept Videos
Nuclear Export of mRNA
Termination of Translation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

